91 related articles for article (PubMed ID: 10790217)
1. Detection of point mutations of BCL10 gene in hepatocellular carcinoma tissues: report of 46 cases.
Jihua C; Xisheng L; Shengli C; Zongxian C; Guang C; Ruyu D
Hum Mutat; 2000 May; 15(5):482-3. PubMed ID: 10790217
[TBL] [Abstract][Full Text] [Related]
2. bcl 10 gene mutation in hepatocellular carcinoma.
Cheng J; Leng X; Cai S; Cao Z; Cao G; Peng J; Wang S; Du R
Chin Med J (Engl); 2001 Jul; 114(7):747-51. PubMed ID: 11780342
[TBL] [Abstract][Full Text] [Related]
3. Bcl10 expression, rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappaB.
Ohshima K; Muta H; Kawasaki C; Muta K; Deyev V; Kanda M; Kumano Y; Podack ER; Kikuchi M
Int J Oncol; 2001 Aug; 19(2):283-9. PubMed ID: 11445840
[TBL] [Abstract][Full Text] [Related]
4. BCL10 in malignant lymphomas--an evaluation using fluorescence in situ hybridization.
Achuthan R; Bell SM; Carr IM; Leek JP; Roberts P; Horgan K; Markham AF; Selby PJ; MacLennan KA
J Pathol; 2002 Jan; 196(1):59-66. PubMed ID: 11748643
[TBL] [Abstract][Full Text] [Related]
5. Lack of Bcl10 mutations in malignant cartilaginous tumors.
Park YK; Park HR; Kim YW; Chi SG; Unni KK
Int J Mol Med; 2002 Mar; 9(3):217-9. PubMed ID: 11836626
[TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of the BCL10 gene in childhood solid malignancies.
Miao J; Kusafuka T; Udatsu Y; Okada A
Med Pediatr Oncol; 2002 Dec; 39(6):543-6. PubMed ID: 12376974
[TBL] [Abstract][Full Text] [Related]
7. [Mutation analysis of the tumor suppressor gene PTEN/MMAC1/TEP1 in human hepatocellular carcinoma].
Zhang LN; Zha XL; Yu Q; He JY
Shi Yan Sheng Wu Xue Bao; 2000 Sep; 33(3):223-7. PubMed ID: 12549040
[TBL] [Abstract][Full Text] [Related]
8. Lack of Bcl10 gene mutations in laryngeal squamous cell carcinoma.
Ronchetti D; Intini D; Pruneri G; Neri A; Pignataro L
J Laryngol Otol; 2002 Aug; 116(8):610-2. PubMed ID: 12389689
[TBL] [Abstract][Full Text] [Related]
9. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma.
Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N
J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452
[TBL] [Abstract][Full Text] [Related]
10. Lack of BCL10 mRNA mutation in lymphold malignancies.
Kawano T; Iwase S; Nakayama R; Horiguchi-Yamada J; Kobayashi M; Yamada H
Anticancer Res; 2002; 22(1A):305-9. PubMed ID: 12017308
[TBL] [Abstract][Full Text] [Related]
11. Point mutations and deletions of the Bcl10 gene in solid tumors and malignant lymphomas.
Lee SH; Shin MS; Kim HS; Park WS; Kim SY; Lee HK; Park JY; Oh RR; Jang JJ; Park KM; Han JY; Kang CS; Lee JY; Yoo NJ
Cancer Res; 1999 Nov; 59(22):5674-7. PubMed ID: 10582682
[TBL] [Abstract][Full Text] [Related]
12. Lack of BCL10 mutations in multiple myeloma and plasma cell leukemia.
Shih LY; Fu JF; Shurtleff SA; Morris SW; Downing JR
Genes Chromosomes Cancer; 2001 Apr; 30(4):402-6. PubMed ID: 11241793
[TBL] [Abstract][Full Text] [Related]
13. [Melanoma antigen-3 expression in human hepatocellular carcinoma].
Cai S; Zhao H; Leng X; Cheng J; Gong S; Peng J; Cong X; Wang Y; Rui J; Hui Y; Du R; Chen W
Zhonghua Wai Ke Za Zhi; 2000 Sep; 38(9):693-6. PubMed ID: 11832142
[TBL] [Abstract][Full Text] [Related]
14. Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma.
Chen GG; Li MY; Ho RL; Chak EC; Lau WY; Lai PB
J Clin Virol; 2005 Sep; 34(1):7-12. PubMed ID: 16087118
[TBL] [Abstract][Full Text] [Related]
15. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.
Ye H; Gong L; Liu H; Hamoudi RA; Shirali S; Ho L; Chott A; Streubel B; Siebert R; Gesk S; Martin-Subero JI; Radford JA; Banerjee S; Nicholson AG; Ranaldi R; Remstein ED; Gao Z; Zheng J; Isaacson PG; Dogan A; Du MQ
J Pathol; 2005 Feb; 205(3):293-301. PubMed ID: 15682443
[TBL] [Abstract][Full Text] [Related]
16. [The relation between p53 mutations and tumor invasiveness of human hepatocellular carcinoma].
Qin L; Tang Z; Liu K
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):405-8. PubMed ID: 8697987
[TBL] [Abstract][Full Text] [Related]
17. [p16 and cyclinD1 protein expression and p16 gene mutation in primary human hepatocellular carcinoma].
Huang GX; Cheng RX; Feng DY
Hunan Yi Ke Da Xue Xue Bao; 2001 Dec; 26(6):527-30. PubMed ID: 12536530
[TBL] [Abstract][Full Text] [Related]
18. Mutations in Bcl10 are very rare in colorectal cancer.
Stone JG; Rowan AJ; Tomlinson IP; Houlston RS
Br J Cancer; 1999 Jul; 80(10):1569-70. PubMed ID: 10408399
[TBL] [Abstract][Full Text] [Related]
19. [Expression of MAGE-1 gene in hepatocellular carcinoma].
Cai S; Chen H; Wang Y
Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):668-72. PubMed ID: 11715455
[TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significance of hepatocellular cancer antigen genes in human hepatocellular carcinoma].
Wang WX; Leng XS; Peng JR; Mu DC; Wang Y; Zhu JY; Du RY; Chen WF
Zhonghua Wai Ke Za Zhi; 2003 Jul; 41(7):506-8. PubMed ID: 12921655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]